Effect of cysteamine. Effect of cysteamine. (A) Comparative inhibitory effect of Vnn1 transfection versus cysteamine (CEA) administration (120 mg/kg i.p.)

Slides:

Advertisements

Similar presentations

Antitumor effect of the combination of IL-2 IC and anti–CTLA-4.

Advertisements

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.

AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.

(A) ZR75-1 cells were treated with 1 μM 5-aza-2′-deoxycytidine (5-Aza) for 4 d. (A) ZR75-1 cells were treated with 1 μM 5-aza-2′-deoxycytidine (5-Aza)

Characterization of R and VR tumors grafted in mice.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

Everolimus Inhibits SMC Proliferation Through Transcriptional Repression of Telomerase (A) Cell proliferation assay in primary murine vascular smooth muscle.

Cocaine exposure downregulates miR-125b expression.

Mitochondrial homeostasis.

Model of Vnn1-induced metabolic rewiring.

Role of HER2 in mediating acquired resistance to EGFR inhibition.

Fig. 5 HDAC inhibition blocks age-dependent diastolic dysfunction.

Characterization of the primary and Ras-transformed myofibroblast cell lines. Characterization of the primary and Ras-transformed myofibroblast cell lines.

MAGs and testes transcript expression levels in the An. gambiae complex. MAGs and testes transcript expression levels in the An. gambiae complex. (A) Percentage.

Analysis of the Warburg signature.

Lack of Vnn1 is associated with the development of aggressive skin STS

eIF5A-PEAK1 signaling regulates KRAS protein expression.

Effect of increasing pantetheinase activity in R tumors.

No correlation between the distance of the duplicated alleles and the transcription levels on each of the alleles. No correlation between the distance.

Highly related T9 and T3 sarcoma cells show distinct tumor growth patterns but similar PD-L1 expression kinetics in vivo. Highly related T9 and T3 sarcoma.

In vivo growth inhibition elicited by afatinib and GSK in a CLU–NRG1-rearranged PDX mouse model. In vivo growth inhibition elicited by afatinib.

ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.

Tumor phenotyping. Tumor phenotyping. (A) Comparative growth behavior of tumors after grafting R versus VR J2A, H1, and I1 cell lines in independent experiments.

Nrf2−/− mice had higher TGF-β1 transcription and FN expression.

Variation analysis for differences between transcription levels on the duplicated alleles. Variation analysis for differences between transcription levels.

MK-8628 modulates transcriptional signatures of activated T lymphocytes. MK-8628 modulates transcriptional signatures of activated T lymphocytes. Gene.

Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.

Inhibition of γ-secretase increased hair cell differentiation by upregulating Math1. a, Expression of Math1 in inner ear stem cells was increased after.

SiRNA directed at Ngn1 inhibited differentiation of inner ear stem cells to β-III tubulin-positive cells. a, Inner ear stem cells treated with siRNA to.

Functional and molecular regeneration in mdx muscle with matrix treatment. Functional and molecular regeneration in mdx muscle with matrix treatment. (A,B)

Skin tumor size following ligand activation of PPARβ/δ and inhibition of COX2. Skin tumor size following ligand activation of PPARβ/δ and inhibition of.

CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.

coTCRcys-transduced T cells control tumor growth in vivo.

In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.

Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c

Inhibitory effect of different doses of IP6 on prostate tumor progression in TRAMP mice. Inhibitory effect of different doses of IP6 on prostate tumor.

Matriptase-2 inhibited breast tumor development in vivo.

Vandetanib decreases tumor incidence and accumulation of HIF-2α, expression of c-Myc and growth factor receptors in the lung of hypoxic mice. Vandetanib.

The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.

A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.

Overexpression of L1 in CRC cells induces NF-κB activation and suppression of p65 expression blocks the capacity to confer liver metastasis. Overexpression.

Bcl-xL expression in tumors antagonizes the therapeutic efficiency of ERBB2 downregulation. Bcl-xL expression in tumors antagonizes the therapeutic efficiency.

Effect of therapy with S247 on the development of liver metastases after 14 and 21 days of tumor growth. Effect of therapy with S247 on the development.

PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models

PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. A, 4T1/HAS3.

Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,

A, tumor growth studies in H1975 tumor–bearing mice.

NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.

WP1066 inhibits the progression of OCIM2 cells through the cell cycle.

HMQ1611 inhibited breast tumor growth in mice.

A to C, MetMAb shows strong antitumor activity in the KP4 orthotopic model of pancreatic cancer by ultrasound. A to C, MetMAb shows strong antitumor activity.

Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent regulation of tumor growth. Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent.

Impact of eNOS expression and treatment with GSNO on prostate tumor growth. Impact of eNOS expression and treatment with GSNO on prostate tumor growth.

Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

Anti-CD40 activates TAMs and recruits inflammatory monocytes.

RhuαVEGF and rhuαVEGF/paclitaxel mediated growth inhibition in an androgen-independent prostate cancer xenograft model. rhuαVEGF and rhuαVEGF/paclitaxel.

TAE-684 effectively inhibits the growth of H3122 in vivo.

In vivo tumor targeting and biodistribution of radiolabeled anti-CEA Fab-H-2Kb/ova conjugates. In vivo tumor targeting and biodistribution of radiolabeled.

PDL192 and inhibit the growth of xenograft tumors.

A, antitumor activity of temozolomide (30 mg/kg for 5 days), talazoparib (0.25 mg/kg twice daily for 5 days), or in combination against “sensitive” Ewing.

Antibody-mediated blockade of the immune-inhibitory PD-1–PD-L1 signaling pathway prolongs survival in poly(I:C)-treated mice. Antibody-mediated blockade.

Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. A,

Increased growth factor receptor expression in lungs and tumors of hypoxic mice. Increased growth factor receptor expression in lungs and tumors of hypoxic.

Biopsies of the vaccination site were obtained 48 h after the first vaccination. Biopsies of the vaccination site were obtained 48 h after the first vaccination.

CPI-444 synergizes with anti–PD-L1 and anti–CTLA-4 treatment.

FGFR2 amplification in primary human gastric tumors predicts for response to NVP-BGJ398. FGFR2 amplification in primary human gastric tumors predicts for.

Wnt5A and ROR2 contribute to intrinsic resistance to BRAF inhibitors.

PD and efficacy of AZD4785 in a KRAS wild-type lung cancer PDX model

DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.

Presentation transcript:

Effect of cysteamine. Effect of cysteamine. (A) Comparative inhibitory effect of Vnn1 transfection versus cysteamine (CEA) administration (120 mg/kg i.p.) on tumor growth in nude mice. For clarity, results are normalized by showing the percentage of growth inhibition comparing VR versus R (VR/R) and CEA-treated versus CEA-untreated R (R CEA/R) tumor growth. (B, C) Effect of cysteamine (CEA) administration on the expression of transcripts associated with hypoxia (B) or differentiation (C). Caroline Giessner et al. LSA 2018;1:e201800073 © 2018 Naquet et al.